DA-1229

DA-1229 · Dong-A Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DA-1229, covering 2009-08-24 to 2023-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD [Phase 2]